- Home
- TATT vs MNPR Comparison
TATT vs MNPR Comparison
Compare TATT & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TATT
- MNPR
- Stock Information
- Founded
- TATT 1985
- MNPR 2014
- Country
- TATT Israel
- MNPR United States
- Employees
- TATT N/A
- MNPR N/A
- Industry
- TATT Aerospace
- MNPR Biotechnology: Pharmaceutical Preparations
- Sector
- TATT Industrials
- MNPR Health Care
- Exchange
- TATT Nasdaq
- MNPR Nasdaq
- Market Cap
- TATT 308.2M
- MNPR 249.5M
- IPO Year
- TATT 1987
- MNPR 2019
- Fundamental
- Price
- TATT $34.14
- MNPR $39.42
- Analyst Decision
- TATT Strong Buy
- MNPR Strong Buy
- Analyst Count
- TATT 1
- MNPR 5
- Target Price
- TATT $35.00
- MNPR $59.50
- AVG Volume (30 Days)
- TATT 140.6K
- MNPR 17.8K
- Earning Date
- TATT 05-21-2025
- MNPR 05-20-2025
- Dividend Yield
- TATT N/A
- MNPR N/A
- EPS Growth
- TATT 96.08
- MNPR N/A
- EPS
- TATT 1.00
- MNPR N/A
- Revenue
- TATT $152,116,000.00
- MNPR N/A
- Revenue This Year
- TATT $18.62
- MNPR N/A
- Revenue Next Year
- TATT $10.62
- MNPR N/A
- P/E Ratio
- TATT $34.74
- MNPR N/A
- Revenue Growth
- TATT 33.68
- MNPR N/A
- 52 Week Low
- TATT $11.84
- MNPR $1.72
- 52 Week High
- TATT $33.83
- MNPR $54.30
- Technical
- Relative Strength Index (RSI)
- TATT 69.05
- MNPR 49.46
- Support Level
- TATT $28.58
- MNPR $37.81
- Resistance Level
- TATT $33.83
- MNPR $44.40
- Average True Range (ATR)
- TATT 1.93
- MNPR 3.61
- MACD
- TATT 0.67
- MNPR -0.38
- Stochastic Oscillator
- TATT 80.30
- MNPR 18.32
About TATT TAT Technologies Ltd.
TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.